Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No guarantees that Baroni evaluation is complete

Hopefully we can maintain a friendlier tone....

As for what have they done for us lately, they have apparently recognized that they need outside expertise in order to capitalize on the decisions they've made re: the acquisitions that many shareholders demanded in order to diversify and create alternate (to the MMP) revenue streams. They made those acquisition decisions/approvals to appease shareholders IMO.

BTW, you may recall I was strongly opposed to any acquisitions, as I knew (and stated) that any new venture would require a lengthy time to show fruit (minimal fruit) and expertise not present within the company, and involve a significant dedication of resources and a great deal of risk. My preference was to invest the MMP wisely/safely (e.g., Treasuries) in addition to doing share buy-backs when the opportunity presented itself.

But they didn't follow my advice (other than share and warrant buy-backs, and a thought-to-be secure investment that turned out different and where PTSC was not the only victim), but that of the vocal shareholders here and elsewhere.

What they have done for us lately is to seek advise from those they believe are expert in the field of PDSG product lines. Good selection? I don't KNOW. Here you may recall my stating, when the consulting contract with Baroni & Co. was announced, that I prefer they seek advice from more than one consulting firm deemed expert in the field, like two or three such firms. This would avoid the possibility/probability of the advice being "skewed" in one particular direction. And it followed the philosophy of the Management Decision-Making Process: identify the problem, develop and examine alternative solutions, pick the best solution. If only one solution (or a set of solutions from a single source) is available, then you haven't properly performed the process. Heck, you may not even identify the real problem you're trying to solve. So there's my criticism of the BoD. A valid one IMO that nobody else has brought forth.

But perhaps this one consulting firm has the answers, and the recommendations desired which will propel PDSG. But, IMO, the BoD through this action is responding to the need, and the (minimal) pressure from shareholders - just like they did when pursuing/permitting the acquisitions.

I admit that I was surprised to read your "I do believe, for the most part, that the intentions of the three most "popular" BOD members have been for the benefit of PTSC over the past 10 years......". That, coupled with your BoD bashing, seems in direct conflict. I further admit that this apparent change in heart raises my suspicions about the motives behind your recent posts. Bash, buy, praise.

Re: what Mr. Caplin "seems to think", you may be jumping to conclusions. He didn't say anything that was untrue and not obvious. When CEOs come and go, but the BoD remains, and the ROI isn't there, of course attention will be directed at the BoD. Is there someone else to whom attention can be directed? (And here you'll recall my stating that attention of shareholders should actually be directed more at the PTO, litigation and infringers - these things are far more important to me than the actions of the BoD regarding some relatively small acquisitions/investments, albeit we have no more influence over these things than we do on the BoD, but they're more worthy of attention, 'cuz that's where the real money is).

I have no viable suggestion on how to replace the current BoD. And neither does anyone else. They are there, and have no incentive to leave - and probably never will. Live with it or leave - nobody is forced to hold PTSC stock. But bitching about it does no good, unless of course you want to buy more. I've used the weather analogy many times. If you don't like the weather, move! Complaining about it won't make it go away.

And while the BoD has occasionally succumed to the demands of shareholders, I believe the line is drawn where their BoD positions are concerned. We may influence some of their decisions, but that decision isn't even on the table.

JMHOs, all things I've posted before over time. Sorry, nothing new.

SGE

Share
New Message
Please login to post a reply